Clinical trial
A Clinical Multicenter, Phase III, Randomized, Double-blind, Prospective and Comparative Trial to Evaluate the Efficacy and Safety of the Combination of Ibuprofen + Caffeine in the Treatment of Headache Attacks, Compared to Ibuprofen Alone.
NCT01172405 is registered in ClinicalTrials.gov with Mantecorp Industria Quimica e Farmaceutica Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Multicenter, Phase III, Randomized, Double-blind, Prospective and Comparative Trial to Evaluate the Efficacy and Safety of the Combination of Ibuprofen + Caffeine in the Treatment of Headache Attacks, Compared to Ibuprofen Alone.
- Lead sponsor
- Mantecorp Industria Quimica e Farmaceutica Ltd.
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- October 31, 2010
- Completion date
- October 31, 2012
- Enrollment
- 144 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.